Research and Markets has announced the addition of the "Global Biochips Markets Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022" report to their offering.

The global biochips market is anticipated to grow at a CAGR of 18.4% during 2016 to 2022. The market has generated $7.63 Billion in 2016 and is anticipated to reach up to $17.65 Billion by 2022. The major driving forces for the market are a rise in diagnosis & treatment of cancer, increase government funding, growth in personalized medicine and technical advances.

In today's world, eczema and food allergies become the most common chronic non-communicable diseases in children in several courtesies. More than 8% of the population are suffering from food allergy, globally in which approximately 6% aged 0-2 years have a food allergy Due to the increase in number of chronic cases such as asthma and multiple sclerosis and diseases like cancer and diabetes increased the demand for biochips has grown worldwide.

North America dominates the global biochips market owing to large number of aging population and broad technical applications of biochips followed by Europe and Asia-Pacific. Asia-Pacific market will drive the growth of the market in future owing to growing economies like India and China.

Companies Mentioned:

  • Affymetrix Inc
  • Agilent Technologies Inc
  • Bio-Rad Laboratories Inc
  • Biochain Institute Inc
  • Biomérieux Sa
  • Caliper Life Sciences In
  • Cepheid Inc
  • Cybrdi Inc
  • Emd Millipore
  • Fluidigm Corp
  • Gamida for Life Group
  • Illumina Inc
  • Imgenex
  • Life Technologies Corp
  • Origene Technologies Inc

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Global Biochips Market By Region

7. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/drpmvz/global_biochips